Healthy Volunteers Clinical Trial
Official title:
Use of the Real-time Position Management (RPM) to Measure the Effects of Continuous Positive Airway Pressure (CPAP) on Duration of Breath Hold and Diaphragm Motion in Normal Volunteers
CPAP will be applied to normal volunteers inorder to understand CPAP's effects on breathing and chest wall motion.
CPAP is a non-invasive ventilation technique that is commonly used to treat sleep apnea.
Using a small air-pump, tubing and facemask, it provides a constant stream of pressurized air
to the upper airways and lungs. Some of the physiological effects noted during CPAP are
hyperinflation of the lungs, stabilizing and flattening of the diaphragm, and decrease in
tidal volume. The effects on duration of breath hold are unknown. During radiation treatment,
these effects are expected to reduce tumor and organ motion which reduces the volume of
normal tissue being irradiated and also creates favorable treatment geometry by moving the
heart away from the anterior chest wall. An important advantage of CPAP compared to other
techniques is that active patient cooperation is not required. The potential exists to
combine use of CPAP with other respiratory management techniques such as breath hold and
improve overall effectiveness. When used in sleep apnea it is well tolerated and poses little
risk to patients. There are no published reports of the use of CPAP in radiation therapy.
In initial studies the Varian RPM system was used to assess respiratory motion with and
without CPAP for patients receiving radiation therapy. This commercially available,
non-invasive system works by directing an infrared beam onto an infrared motion detector that
is placed on the patients' upper abdomen. The detector records the change in abdomen position
that occurs with respiration as a change in amplitude of the detector position. Interventions
that effect respiration will be recorded by an increase or decrease in the amplitude of the
detector motion. When used in breath hold, the detector remains in a fixed position with a
very narrow gating window.
Based on initial experience with the RPM system, it has been found that approximately 1 hour
of CPAP use is required to reduce diaphragm motion. Although early results are favorable
using this approach, it is not certain that this is the best or most efficient method of use
for all patients. The use of CPAP combined with breath hold techniques has not been studied.
The objectives of this study are to use the RPM system in normal volunteers to:
1. Study the effects of CPAP on diaphragm motion to allow better optimization for the use
of CPAP as a respiratory management technique during free breathing.
2. Determine the feasibility of use of CPAP as a respiratory aid for use in patients
treated with breath hold techniques. Determine the effects of CPAP on duration;
reproducibility and tolerance of the breath hold technique.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |